Filing Details
- Accession Number:
- 0001209191-20-006950
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-02-05 16:50:04
- Reporting Period:
- 2020-02-03
- Accepted Time:
- 2020-02-05 16:50:04
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1550395 | David Altshuler | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Evp, Global Research And Cso | No | Yes | No | No |
Transaction Summary
| Sold: | 4,126 shares | Avg. Price: $231.18 | Total Value: $953,861.49 |
| Number of Shares After Transactions: | 31,553 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-02-03 | 1,796 | $91.05 | 33,349 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2020-02-03 | 2,330 | $86.52 | 35,679 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-02-03 | 749 | $229.35 | 34,930 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-02-03 | 785 | $230.60 | 34,145 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-02-03 | 2,122 | $231.67 | 32,023 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-02-03 | 470 | $232.88 | 31,553 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-02-03 | 1,796 | $0.00 | 1,796 | $91.05 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-02-03 | 2,330 | $0.00 | 2,330 | $86.52 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2026-02-01 | No | 4 | M | Direct | |
| 9,320 | 2027-02-02 | No | 4 | M | Direct |
Footnotes
- Transaction made pursuant to Dr. Altshuler's company approved trading plan under Rule 10b5-1.
- Open market sales reported on this line occurred at a weighted average price of $229.35 (range $229.00 to $229.93).
- Dr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $230.60 (range $230.30 to $231.11).
- Open market sales reported on this line occurred at a weighted average price of $231.67 (range $231.31 to $232.28).
- Open market sales reported on this line occurred at a weighted average price of $232.88 (range $232.43 to $233.16).
- Fully vested.
- The option vests in 16 quarterly installments from 02/03/2017.
Billionaire Hedge Funds
